Robert Bayless C.V.

 

ROBERT K. BAYLESS

   8710 Chisholm Lane

                                            Austin, Texas  78748

                                      Methylgroup@sbcglobal.net

                                                   512 280 5687

 

I am an antibiotic researcher who has discovered a new class of non-mutagenic protein synthesis inhibitors to control bacterial infections in humans, animals, and plants. I believe that the human body has evolved an antibiotic to control the overgrowth of bacteria found in the everyday environment, and I know what it is and how to make it.

 

EXPERIENCE

 

January 1980 to present: For the last 35 years, I have been involved in an antibiotic research project. In 1985, I founded and ran a basic biochemistry research lab with a Stanford Ph.D., who trained me in the basics of scientific research. We worked together for ten years. I arranged two clinical trials in cats and dogs to investigate the utility of one of our compounds. I then collaborated for ten years with an MD who was the chief of Emergency Medicine at the Austin city hospital. We arranged and performed two human clinical trials using compounds outlined in my six patents. We had a third trial arranged when he retired after the hospital was taken private. I then spent five years studying analytical chemistry with the Ph.D. Director of the Microanalysis Lab at UT Austin.

I have successfully synthesized a member of a new class of antibiotics based on the hypothesis that the human body has evolved a safe, non-mutagenic protein synthesis inhibitor to control bacteria. The spectroscopist and I explored and defined the chemical structure of the antibiotic compound I synthesized as part of my ongoing research. My efforts now are centered on raising the $5 million necessary to obtain US and worldwide patents on the compounds and then license their testing, manufacture, and use to Big Pharma.

  

EDUCATION

 1977:  Pasted the testing and was accepted into Mensa International.

1972-1973: Pace University Graduate School of Business located on the Pleasantville/Briarcliff Campus in upstate New York. I completed one year of a two-year MBA program but left because they did not offer coursework in entrepreneurship.

1965-1969: Earned a B.A. from The University of Connecticut located in Storrs, Connecticut.

  

                                                   PATENTS

 1)   Treating AIDS and HIV Infection with Methionine  United States 5,292,773    Issued March 8, 1994  2 inventors:  Robert Bayless and  Gerald P. Hirsch,  Ph.D.

2)   Treating AIDS and HIV Infection with Methionine Compositions.          Continuation-in-part of above patent.     United States  5,430,064     Issued July 4, 1995   2 inventors:  Robert Bayless and Gerald P. Hirsch, Ph.D.

3)   Treating Inflammatory Pain with Methionine     United States  5,053,429 Issued Oct. 1, 1991   2 inventors:  Robert Bayless  and Gerald P. Hirsch,  Ph.D.

4)   Antioxidant Compositions and Methods Ameliorating Inflammatory Symptoms of Respiratory Disease     United States 4,927,850     Issued May 22, 1990        2 inventors:  Robert Bayless and Gerald P. Hirsch,  Ph.D.

5)   Calcium Homeostasis Compositions and Methods for Controlling Calcium Metabolism   United States 4,902,718    Issued February 20, 1990                                     2 inventors:  Robert Bayless and Gerald. P. Hirsch, Ph.D.

6)   Methods for Inhibiting Inflammatory Ischemic, Thrombotic and Cholesterolemic Disease Response with Methionine Compounds              United States 5,084,482 Issued January 28, 1992        2 inventors:  Robert Bayless and Gerald P. Hirsch, Ph.D.

 

REFERENCES

Earl Matthew  M.D.                                             Paul Lebourgeois  M.D.

earlmatthewmd@yahoo.com                                           Paul@Lebourgeois.org